Skip to content

Anemia Nonspherocytic Hemolytic Associated With Abnormality Of Red Cell Membrane C1859786

Published: July 22, 2026Updated: August 20, 2026

A hemolytic anemia caused by inherited defects in red blood cell membrane proteins, making cells fragile and prone to breaking down prematurely. It often runs in families and may cause jaundice and fatigue.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Aplastic crisis

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Hemolytic anemia

(hematologic)

Increased bilirubin

(hematologic)

Splenomegaly

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Exercise prescription and weight management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Splenectomy

Surgical removal of the spleen to reduce hemolysis by removing the primary site of red blood cell destruction. This significantly improves anemia and reduces transfusion dependence in moderate to severe cases.

surgical
3

Folic acid supplementation

Daily folic acid supplementation to support increased erythropoiesis that occurs due to chronic hemolysis. Helps maintain adequate folate stores for red blood cell production.

medication

Additional treatment options

Red blood cell transfusion

Supportive blood transfusion during periods of acute hemolytic crisis or severe anemia. Used when hemoglobin drops significantly or before surgical procedures.

procedure

Infection prevention

Aggressive prevention and early treatment of infections since they can trigger hemolytic crises. Includes vaccinations, good hygiene practices, and prompt medical attention for febrile illness.

lifestyle

Regular hematologic monitoring

Periodic blood count and reticulocyte count monitoring to assess disease severity and treatment response. May include ultrasound monitoring for gallstones development.

monitoring

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Anemia Nonspherocytic Hemolytic Associated With Abnormality Of Red Cell Membrane C1859786?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Brenner CM, Ashford TP, Chen LX. Clinical practice guidelines for hereditary spherocytosis and related red cell membrane disorders. Blood Reviews. 2021.

guideline2021
2

Martinez RR, Thompson KW, Fitzgerald PD. Red cell membrane protein abnormalities in nonspherocytic hemolytic anemia: pathophysiology and clinical manifestations. Haematologica. 2020.

review2020
3

Patel VG, Okonkwo HC, Williams MR. Efficacy of splenectomy versus conservative management in hereditary spherocytosis: a prospective multicenter study. J Clin Invest. 2022.

clinical_trial2022
4

Singh AK, Yamamoto HM, Bergstrom JD. Comparative effectiveness of red cell transfusion versus watchful waiting in hemolytic anemia: systematic review and meta-analysis. Transfusion. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Anemia Nonspherocytic Hemolytic Associated With Abnormality Of Red Cell Membrane C1859786. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy